Yuejin Hua Selected Research

DNA polymerase mu

1/2021

Mechanism of genome instability mediated by human DNA polymerase mu misincorporation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuejin Hua Research Topics

Disease

6	Genomic Instability 01/2021 - 06/2005
3	Neoplasms (Cancer) 10/2018 - 02/2015
1	Polyps 11/2021
1	Ovarian Epithelial Carcinoma 09/2018
1	Ovarian Neoplasms (Ovarian Cancer) 09/2018
1	Breast Neoplasms (Breast Cancer) 02/2015

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2005
1	exopolyphosphataseIBA 11/2021
1	IonsIBA 11/2021
1	Phosphates (Orthophosphate)IBA 11/2021
1	PolymersIBA 11/2021
1	PolyphosphatesIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	DNA polymerase muIBA 01/2021
1	deoxyguanosine triphosphate (dGTP)IBA 01/2021
1	DNA Ligases (Ligases, DNA)IBA 01/2021
1	DNA-(Apurinic or Apyrimidinic Site) Lyase (AP Endonuclease)IBA 01/2020
1	DNA Repair EnzymesIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018
1	Sodium Citrate FDA LinkGeneric 10/2018
1	GoldIBA 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 09/2018
1	Pyrimidine DimersIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2015
1	Flap EndonucleasesIBA 02/2015
1	Pharmaceutical PreparationsIBA 02/2015
1	Transcription Factors (Transcription Factor)IBA 02/2015
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2015
1	RecQ HelicasesIBA 02/2007

Therapy/Procedure

1	Therapeutics 02/2015